lilly obesity pill - Search News

News

Eli Lilly weight loss pill shows promise

Eli Lilly’s Obesity Pill Shows Promising Weight Loss in New Results

In an 18-month clinical trial of the experimental GLP-1 pill orforglipron, about 60 percent of people lost at least 10 percent of their body weight.

Indianapolis Star on MSN · 14h

Eli Lilly closer to breakthrough weight loss drug; shares tumble as some question results

Eli Lilly is one step closer to bringing an oral weight loss medicine to the booming obesity drug market. A clinical trial saw people lose 12% of body weight.

U.S. News & World Report · 1h

New Weight Loss Pill From Eli Lilly Shows Promise in Early Study

FRIDAY, Aug. 8, 2025 (HealthDay News) — A new weight loss pill made by Eli Lilly helped people lose a significant amount of weight in a recent study. Taken at the highest dose, orforglipron helped patients lose an average 27.3 pounds, or 12.4% of their body weight, over 72 weeks.

InvestorsHub on MSN6h

Novo Nordisk Shares Climb for Second Day as Lilly’s Obesity Pill Falls Short of Wegovy in Trial

Shares of Novo Nordisk (NYSE:NVO), traded in Copenhagen, rose over 5% on Friday, extending gains from the previous session.

1d

Lilly's obesity pill lags Novo's Wegovy injection in key trial

Eli Lilly said on Thursday that its experimental GLP-1 pill helped patients lose 12.4% of their body weight after 72 weeks in ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results